Error: Could not add to watchlist. X

Tekla Life Sciences Investors

+ Watchlist
HQL:US
New York
29.86
USD
0.30
1.01%
As of 20:04:07 ET on 08/01/2015.
Open
29.64
Day Range
29.51 - 29.86
Previous Close
29.56
52Wk Range
19.24 - 31.21
1 Yr Return
54.27%
YTD Return
24.50%
Open
29.64
Day Range
29.51 - 29.86
Volume
69,786
Previous Close
29.56
52Wk Range
19.24 - 31.21
1 Yr Return
54.27%
YTD Return
24.50%
NAV (on 07/31/2015)
29.79
Total Assets (m -) (on 06/26/2015)
562.317
Inception Date
05/08/1992
Premium/Discount
0.23%
Average 52-Week Premium
-0.90%
Fund Managers
DANIEL R OMSTEAD "DAN"
Last Dividend (on 05/22/2015)
0.54
Dividend Indicated Gross Yield
7.23%
Expense Ratio
1.32%
3 Mo Return
15.38%
3 Yr Return
37.39%
5 Yr Return
38.79%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 436.32 k 50.30 m 9.58
Gilead Sciences Inc 443.12 k 43.48 m 8.28
Biogen Inc 69.08 k 29.17 m 5.56
Regeneron Pharmaceuticals Inc 54.52 k 24.62 m 4.69
Incyte Corp 259.92 k 23.82 m 4.54
Alexion Pharmaceuticals Inc 127.80 k 22.15 m 4.22
Teva Pharmaceutical Industries 287.32 k 17.90 m 3.41
Amgen Inc 107.12 k 17.12 m 3.26
Vertex Pharmaceuticals Inc 138.16 k 16.30 m 3.10
BioMarin Pharmaceutical Inc 128.43 k 16.01 m 3.05
Profile
Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
ADDRESS
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
PHONE
1-617-772-8500